Related trials
ZEST AMI (vs SES), 2009 - zotarolimus ES vs sirolimus ES
TRIANA, 2009 - primary ballon angioplasty vs tenecteplase
DEBATER (SES vs BMS), 2009 - sirolimus ES vs bare-metal stent
NORDISTEMI, 2009 - thrombolysis + angioplasty vs immediate thrombolysis
Juwana, 2009 - sirolimus ES vs paclitaxel ES
ZEST AMI (vs PES), 2009 - zotarolimus ES vs paclitaxel ES
PASEO, 2009 - drug ES vs bare-metal stent
CARESS, 2008 - thrombolysis + angioplasty vs immediate thrombolysis
HORIZONS-AMI Stent, 2008 - paclitaxel ES vs bare-metal stent
MISSION, 2008 - sirolimus ES vs bare-metal stent
DEDICATION, 2008 - drug ES vs bare-metal stent
Díaz de la Llera, 2007 - sirolimus ES vs bare-metal stent
SESAMI, 2007 - sirolimus ES vs bare-metal stent
TYPHOON, 2006 - sirolimus ES vs bare-metal stent
PROSIT, 2006 - sirolimus ES vs paclitaxel ES
HAAMU-STENT, 2006 - paclitaxel ES vs bare-metal stent
PASSION, 2006 - paclitaxel ES vs bare-metal stent
WEST, 2006 - systematic PCI (+stent) vs no systematic PCI
CAPITAL AMI, 2005 - thrombolysis + angioplasty vs immediate thrombolysis
Di Lorenzo et al., 2005 - sirolimus ES vs paclitaxel ES
ZWOLLE 6, 2005 - primary stenting vs ballon angioplasty
CAPITAL AMI, 2005 - systematic PCI (+stent) vs no systematic PCI
senior PAMI, 2005 - primary PCI vs thrombolytic therapy
STOPAMI 3, 2004 - primary stenting vs ballon angioplasty
GRACIA-1, 2004 - systematic PCI (+stent) vs no systematic PCI
See also:
All acute myocardial infarction clinical trials
All clinical trials of PCI
All clinical trials of immediate systematic ballon angioplastyte
|
|
TAMI-5 (Califf) study, 1991
|
|
|
Treatments
| Studied treatment |
immediate catheterization with angioplasty for failed thrombolysis (90min after rtPA/urokinase)
|
| Control treatment |
deferred predischarge catheterization on days 5-10, no PTCA planned
|
| Concomittant treatment |
rtPA, urokinase |
| Remarks |
3 x 2 factorial design (2nd factor: t-PA vs urokinase vs both) |
Patients
| Patients |
patient with acute myocardial infarction |
| Exclusion criteria |
contraindications to thrombolytic therapy; cardiogenic shock; age of more than 75 years |
Method and design
| Randomized effectives |
287 / 288 (studied vs. control) |
| Design |
Factorial plan |
Results
No results available for this trial
- no clinical endpoint reported
Reference(s)
-
Califf RM, Topol EJ, Stack RS, Ellis SG, George BS, Kereiakes DJ, Samaha JK, Worley SJ, Anderson JL, Harrelson-Woodlief L.
Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group..
Circulation 1991;83:1543-56
Pubmed
|
Hubmed
| Fulltext
|